Pulished Date August, 2019
ID: 215
Share on
Share on

Asia Pacific Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 215
Pages: 145

APAC Antifungal Drugs Market Size & Growth (2019 - 2024)

Antifungal Drugs Market in the Asia Pacific is estimated at $2.09 billion in 2018 and is poised to be growing at a CAGR of 4.1%, to reach $2.55 billion by 2023. In the following few years, the market is projected to grow enormously with the growing global population.

Antifungal drugs are used to cure fungal infections which are usually caused by the unclean, unhygienic and damp environments. Fungal infections are the invasion of epithelial tissue by microscopic organisms. Systemic fungal infections are caused by indigestion or inhalation of fungus spores and cause fungal pneumonia and opportunistic fungus causes diseases like candidiasis, meningitis, mucormycosis, etc. Most of the fungal infections and fungal diseases are generally non-lethal but they are very uncomfortable to live with. Commonly occurring fungal infections are responsible for the rise of the antifungal drugs market. Antifungal drugs work through various mechanisms such as inhibiting cell wall formation, cell membrane disruption, and cell division.

The major factors driving the market are rising awareness of fungal infections with the increasing incidence of antifungal infections all over the world, rising government and corporate funding in the industry. Further, more and more development of public-private partnerships in the pharmaceutical industry and the rising popularity of over-the-counter antifungal drugs for dermal infections are vastly responsible for increasing the market size. Also, the increase of population with weak, in whom the occurrence of fungal infections is much more than average, will drive the market. Existing high penetration of conventional drugs used for the treatment of fungal infections is restraining the Asia-Pacific Antifungal drugs market’s growth.

The key challenges faced by the Asia-Pacific Antifungal drugs market are the cost of drugs and their effectiveness in treatments. As many countries in Asia-Pacific are having emerging economies, the antifungal drug market in the region is going to grow fastest.

This report segmented the APAC Antifungal Drugs Market into the following categories:

  • By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines and Others
  • By Therapeutic Indications: Aspergillosis, Dermatophytosis, Candidiasis and Others
  • By Application: Powders, Ointments, Drugs and Pastes
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, The Antifungal drugs market in Asia-Pacific is the fastest-growing followed by Latin America. India's antifungal drug market is the fastest growing in the Asia-pacific region.

Major market players dominating the market, include Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Bayer Healthcare, Kramer Laboratories, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                6.3 Asia-Pacific 

                                6.1 Introduction

                                6.2 China 

                                6.3 India 

                                6.4 Japan 

                                6.5 South Korea

                                6.6 Australia

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Antifungal Drugs Market By Region, From 2019 - 2024 (USD Million)
  2. Asia-Pacific Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  3. Asia-Pacific Echinocandins Market By Region, From 2019 - 2024 (USD Million)
  4. Asia-Pacific Azoles Market By Region, From 2019 - 2024 (USD Million)
  5. Asia-Pacific Polyenes Market By Region, From 2019 - 2024 (USD Million)
  6. Asia-Pacific Allylamines Market By Region, From 2019 - 2024 (USD Million)
  7. Asia-Pacific Other Drugs Market By Region, From 2019 - 2024 (USD Million)
  8. Asia-Pacific Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  9. Asia-Pacific Aspergillosis Market By Region, From 2019 - 2024 (USD Million)
  10. Asia-Pacific Dermatophytosis Market By Region, From 2019 - 2024 (USD Million)
  11. Asia-Pacific Candidiasis Market By Region, From 2019 - 2024 (USD Million)
  12. Asia-Pacific Other Therapeutic Indications Market By Region, From 2019 - 2024 (USD Million)
  13. Asia-Pacific Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)
  14. Asia-Pacific Powders Market By Region, From 2019 - 2024 (USD Million)
  15. Asia-Pacific Ointments Market By Region, From 2019 - 2024 (USD Million)
  16. Asia-Pacific Drugs Market By Region, From 2019 - 2024 (USD Million)
  17. Asia-Pacific Pastes Market By Region, From 2019 - 2024 (USD Million)
  18. China Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  19. China Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  20. China Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)
  21. India Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  22. India Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  23. India Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)
  24. Japan Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  25. Japan Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  26. Japan Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)
  27. South Korea Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  28. South Korea Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  29. South Korea Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)
  30. Australia Antifungal Drugs Market By Drug Type, From 2019 - 2024 (USD Million)
  31. Australia Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024 (USD Million)
  32. Australia Antifungal Drugs Market By Application, From 2019 - 2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample